Yingyi Wu

Yingyi Wu

Auto-generated profile, based on publicly available information

Yingyi Wu

Department of Rheumatology and Immunology, China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 December 2020 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
MYMin Yang
Min Yang
ZXZhanxue Xu
Zhanxue Xu
HYHailan Yan
Hailan Yan
HTHsiang-i Tsai
Hsiang-i Tsai
DSDandan Su
Dandan Su
FCFang Cheng
Fang Cheng
Organ transplantation has been employed upon serious injuries, but a T-cell-mediated potent inflammatory immune response often leads to graft rejection. Immunosuppressive drugs such as rapamycin (RAPA) have to be taken after organ transplantation, but long-term use of these drugs causes severe adverse effects. Immune checkpoint pathways such as the programmed death-receptor 1/programmed death-ligand 1 (PD-1/PD-L1) provides an immunosuppressive environment, preventing excessive tissue destruction due to inflammatory immune responses. In this study, we bioengineered cell membrane-derived PD-L1 nanovesicles (PD-L1 NVs) to carry low doses of RAPA. These NVs inhibited T-cell activation and proliferation in vitro, by enhancing the PD-1/PD-L1 immune co-inhibitory signaling axis and inhibiting the mTOR pathway. Importantly, PD-L1 NVs encapsulated with rapamycin exerted stronger effects on inhibiting T-cell proliferation than PD-L1 NVs or rapamycin alone. This can be recapitulated in a mouse skin transplantation model, leading to the weakened alloimmune response and allograft tolerance. We also found that PD-L1/rapamycin vesicles have additional function to induce regulatory T cells in the recipient spleens. Our study highlighted the power of combining low-dose rapamycin and PD-L1 in the nanovesicles as immunosuppressants to promote allograft acceptance.

5 August 2024 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
YWYingyi Wu
Yingyi Wu
HTHsiang-I Tsai
Hsiang-I Tsai
HZHuiming Zhu
Huiming Zhu
YZYongqiang Zhang
Yongqiang Zhang
SLShanshan Liu
Shanshan Liu
LSLingyun Sun
Lingyun Sun

30 December 2021 in Gynecology & Reproductive Health
Verified
Journal Article
Open access
BJBasu Jayasri
Basu Jayasri
OSOraee Sara
Oraee Sara
WYWu Yingyi
Wu Yingyi
EDEncalada M Diana
Encalada M Diana
MLMolina Lara
Molina Lara
MMMikhail Magdy
Mikhail Magdy